Study Stopped
early discontinuation based on strategic sponsor decision not driven by any safety concern
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
BOREALIS-AF
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
2 other identifiers
interventional
3,773
45 countries
520
Brief Summary
The objective is to evaluate whether once weekly subcutaneous (SC) injection of idrabiotaparinux sodium (biotinylated idraparinux) is at least as efficient to prevent clots in brain and in the other organs than oral international normalized ratio (INR) adjusted-dose warfarin in patients with atrial fibrillation (AF).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 atrial-fibrillation
Started Dec 2007
520 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 21, 2007
CompletedFirst Posted
Study publicly available on registry
December 24, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedMarch 21, 2016
February 1, 2016
2.8 years
December 21, 2007
February 19, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite of all fatal or non-fatal strokes or non central nervous system (CNS) systemic embolic events (SE)
From randomization up to the end of the treatment period (minimum of 6 months)
Secondary Outcomes (2)
Components of the primary study outcome measure:
From randomization up to the end of the treatment period (minimum of 6 months)
Composite of stroke or non CNS SE or myocardial infarction (MI) or venous thromboembolism (VTE) or major bleeding or death
From randomization up to the end of the treatment period (minimum of 6 months)
Study Arms (2)
Idrabiotaparinux
EXPERIMENTALIdrabiotaparinux sodium, 3.0 mg, once-weekly for 7 weeks followed a maintenance dosing adjusted according to the age and to the renal function for a minimum total treatment duration of 6 months. Avidin, 100 mg, at the discretion of the investigator whenever deemed appropriate and possible (ie, life-threatening bleeding, emergency invasive procedure with the potential of uncontrolled bleeding, or overdosage).
Warfarin
ACTIVE COMPARATORWarfarin, INR-adjusted dose, for a minimum total treatment duration of 6 months.
Interventions
Pre-filled syringes containing: * 0.5 mL for the 3.0 mg dosage; * 0.33 mL for the 2.0 mg dosage (maintenance dosage for participants with mild renal impairment and less than 75 years old); * 0.25 mL for the 1.5 mg dosage (maintenance dosage for participants with moderate renal impairment or age ≥75 years). Subcutaneous injection
Capsules with 1 or 5 mg for INR-adjusted dose (INR checked at least once a month) Oral administration
Matching pre-filled syringes containing: * 0.5 mL for the 3.0 mg dosage; * 0.33 mL for the 2.0 mg dosage (maintenance dosage for participants with mild renal impairment and less than 75 years old); * 0.25 mL for the 1.5 mg dosage (maintenance dosage for participants with moderate renal impairment or age ≥75 years). Subcutaneous injection
Vial containing 105 mg of lyophilized powder for dilution Intravenous infusion for 30 minutes
Vial containing 105 mg of matching lyophilized powder for dissolution Intravenous infusion for 30 minutes
Eligibility Criteria
You may qualify if:
- Non valvular atrial fibrillation (AF)
- Indication for long-term Vitamin-K antagonist (VKA) therapy based on the presence of previous ischemic stroke, transient ischemic attack (TIA) or systemic embolism and/or at least two of the following risk factors: hypertension requiring drug treatment, moderately or severely impaired left ventricular function and/or congestive heart failure, age \> or = 75 years, diabetes mellitus.
You may not qualify if:
- Indication for VKA other than AF
- Stroke or TIA within previous 5 days
- Transient AF caused by a reversible disorder
- Planned major surgery/trauma or cardioversion within 30 days
- INR \> 3 at baseline
- Active bleeding or high risk of bleeding
- Uncontrolled hypertension
- Pregnancy or childbearing potential without proper contraceptive measures or breast feeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sanofilead
Study Sites (538)
Sanofi-Aventis Investigational Site Number 840227
Mobile, Alabama, 36608, United States
Sanofi-Aventis Investigational Site Number 840209
Tucson, Arizona, 85723, United States
Sanofi-Aventis Investigational Site Number 840255
Little Rock, Arkansas, 72204, United States
Sanofi-Aventis Investigational Site Number 840224
Little Rock, Arkansas, 72205, United States
Sanofi-Aventis Investigational Site Number 840179
Mountain Home, Arkansas, 72653, United States
Sanofi-Aventis Investigational Site Number 840270
Beverly Hills, California, 90210, United States
Sanofi-Aventis Investigational Site Number 840278
Beverly Hills, California, 90211, United States
Sanofi-Aventis Investigational Site Number 840241
Burbank, California, 91505, United States
Sanofi-Aventis Investigational Site Number 840010
Corona, California, 92879, United States
Sanofi-Aventis Investigational Site Number 840195
Encino, California, 91436, United States
Sanofi-Aventis Investigational Site Number 840033
Loma Linda, California, 92354, United States
Sanofi-Aventis Investigational Site Number 840184
Long Beach, California, 90813, United States
Sanofi-Aventis Investigational Site Number 840183
Los Banos, California, 93635, United States
Sanofi-Aventis Investigational Site Number 840272
Northridge, California, 91325, United States
Sanofi-Aventis Investigational Site Number 840213
Orange, California, 92868, United States
Sanofi-Aventis Investigational Site Number 840009
Redondo Beach, California, 90277, United States
Sanofi-Aventis Investigational Site Number 840298
Riverside, California, 92501, United States
Sanofi-Aventis Investigational Site Number 840264
San Diego, California, 92103, United States
Sanofi-Aventis Investigational Site Number 840275
San Diego, California, 92128, United States
Sanofi-Aventis Investigational Site Number 840103
Santa Ana, California, 92704, United States
Sanofi-Aventis Investigational Site Number 840002
Santa Rosa, California, 95405, United States
Sanofi-Aventis Investigational Site Number 840111
Torrance, California, 90505, United States
Sanofi-Aventis Investigational Site Number 840118
Visalia, California, 93291, United States
Sanofi-Aventis Investigational Site Number 840268
Bridgeport, Connecticut, 06610, United States
Sanofi-Aventis Investigational Site Number 840246
Bay Pines, Florida, 33744, United States
Sanofi-Aventis Investigational Site Number 840066
Beach, Florida, 32168, United States
Sanofi-Aventis Investigational Site Number 840313
Brandon, Florida, 33511, United States
Sanofi-Aventis Investigational Site Number 840084
Dunnellon, Florida, 34432, United States
Sanofi-Aventis Investigational Site Number 840138
Fort Lauderdale, Florida, 33308, United States
Sanofi-Aventis Investigational Site Number 840220
Fort Lauderdale, Florida, 33316, United States
Sanofi-Aventis Investigational Site Number 840215
Gainesville, Florida, 32608, United States
Sanofi-Aventis Investigational Site Number 840131
Hollywood, Florida, 33021, United States
Sanofi-Aventis Investigational Site Number 840161
Hollywood, Florida, 33021, United States
Sanofi-Aventis Investigational Site Number 840234
Key West, Florida, 33040, United States
Sanofi-Aventis Investigational Site Number 840112
Lake Mary, Florida, 32746, United States
Sanofi-Aventis Investigational Site Number 840053
Lakeland, Florida, 33805, United States
Sanofi-Aventis Investigational Site Number 840198
Melbourne, Florida, 32901, United States
Sanofi-Aventis Investigational Site Number 840117
Miami, Florida, 33156, United States
Sanofi-Aventis Investigational Site Number 840003
Niceville, Florida, 32578, United States
Sanofi-Aventis Investigational Site Number 840230
Ocala, Florida, 34471, United States
Sanofi-Aventis Investigational Site Number 840202
Orlando, Florida, 32803, United States
Sanofi-Aventis Investigational Site Number 840306
Orlando, Florida, 32822, United States
Sanofi-Aventis Investigational Site Number 840022
Ormond Beach, Florida, 32174, United States
Sanofi-Aventis Investigational Site Number 840110
Palm Harbor, Florida, 34684, United States
Sanofi-Aventis Investigational Site Number 840211
Plantation, Florida, 33317, United States
Sanofi-Aventis Investigational Site Number 840116
Sanford, Florida, 32271, United States
Sanofi-Aventis Investigational Site Number 840243
Spring Hill, Florida, 34609, United States
Sanofi-Aventis Investigational Site Number 840082
St. Petersburg, Florida, 33701, United States
Sanofi-Aventis Investigational Site Number 840012
St. Petersburg, Florida, 33707, United States
Sanofi-Aventis Investigational Site Number 840073
Atlanta, Georgia, 30342, United States
Sanofi-Aventis Investigational Site Number 840273
Augusta, Georgia, 30909, United States
Sanofi-Aventis Investigational Site Number 840204
Columbus, Georgia, 31904-5245, United States
Sanofi-Aventis Investigational Site Number 840290
Columbus, Georgia, 31904, United States
Sanofi-Aventis Investigational Site Number 840225
Columbus, Georgia, 31907, United States
Sanofi-Aventis Investigational Site Number 840305
Dunwoody, Georgia, 30338, United States
Sanofi-Aventis Investigational Site Number 840165
Savannah, Georgia, 31405, United States
Sanofi-Aventis Investigational Site Number 840130
Idaho Falls, Idaho, 83404, United States
Sanofi-Aventis Investigational Site Number 840228
Idaho Falls, Idaho, 83404, United States
Sanofi-Aventis Investigational Site Number 840143
Nampa, Idaho, 83686, United States
Sanofi-Aventis Investigational Site Number 840221
Chicago, Illinois, 60637, United States
Sanofi-Aventis Investigational Site Number 840206
Chicago, Illinois, 60664, United States
Sanofi-Aventis Investigational Site Number 840280
Beaver City, Indiana, 15009, United States
Sanofi-Aventis Investigational Site Number 840014
Elkhart, Indiana, 46514, United States
Sanofi-Aventis Investigational Site Number 840249
Wichita, Kansas, 67208, United States
Sanofi-Aventis Investigational Site Number 840265
Lexington, Kentucky, 40504, United States
Sanofi-Aventis Investigational Site Number 840047
Alexandria, Louisiana, SUITE 250, United States
Sanofi-Aventis Investigational Site Number 840218
Jena, Louisiana, 71342, United States
Sanofi-Aventis Investigational Site Number 840247
Lafayette, Louisiana, 70503, United States
Sanofi-Aventis Investigational Site Number 840158
Lake Charles, Louisiana, 70601, United States
Sanofi-Aventis Investigational Site Number 840077
Natchitoches, Louisiana, 71457, United States
Sanofi-Aventis Investigational Site Number 840259
Shreveport, Louisiana, 71103, United States
Sanofi-Aventis Investigational Site Number 840231
Shreveport, Louisiana, 71105, United States
Sanofi-Aventis Investigational Site Number 840232
Shreveport, Louisiana, 71105, United States
Sanofi-Aventis Investigational Site Number 840145
Auburn, Maine, 04210, United States
Sanofi-Aventis Investigational Site Number 840017
Baltimore, Maryland, 21237, United States
Sanofi-Aventis Investigational Site Number 840317
Denton, Maryland, 76201, United States
Sanofi-Aventis Investigational Site Number 840311
Alpena, Michigan, 49707, United States
Sanofi-Aventis Investigational Site Number 840276
Brighton, Michigan, 48114, United States
Sanofi-Aventis Investigational Site Number 840242
Detroit, Michigan, 48236, United States
Sanofi-Aventis Investigational Site Number 840253
Grand Rapids, Michigan, 49503, United States
Sanofi-Aventis Investigational Site Number 840137
Saint Clair Shores, Michigan, 48081, United States
Sanofi-Aventis Investigational Site Number 840134
Saint Cloud, Minnesota, 56303, United States
Sanofi-Aventis Investigational Site Number 840067
Gulfport, Mississippi, 39503, United States
Sanofi-Aventis Investigational Site Number 840006
Picayune, Mississippi, 39466, United States
Sanofi-Aventis Investigational Site Number 840201
St Louis, Missouri, 63104, United States
Sanofi-Aventis Investigational Site Number 840310
St Louis, Missouri, 63122, United States
Sanofi-Aventis Investigational Site Number 840200
St Louis, Missouri, 63128, United States
Sanofi-Aventis Investigational Site Number 840323
St Louis, Missouri, 63141, United States
Sanofi-Aventis Investigational Site Number 840096
Anaconda, Montana, 59711, United States
Sanofi-Aventis Investigational Site Number 840008
Butte, Montana, 59701, United States
Sanofi-Aventis Investigational Site Number 840126
Fremont, Nebraska, 68025, United States
Sanofi-Aventis Investigational Site Number 840051
Las Vegas, Nevada, 89119, United States
Sanofi-Aventis Investigational Site Number 840258
Las Vegas, Nevada, 89144, United States
Sanofi-Aventis Investigational Site Number 840303
Hamilton, New Jersey, 08690, United States
Sanofi-Aventis Investigational Site Number 840109
Linden, New Jersey, 07036, United States
Sanofi-Aventis Investigational Site Number 840024
Morristown, New Jersey, 07962-1956, United States
Sanofi-Aventis Investigational Site Number 840102
Buffalo, New York, 14209, United States
Sanofi-Aventis Investigational Site Number 840152
Johnson City, New York, 13790, United States
Sanofi-Aventis Investigational Site Number 840159
Rochester, New York, 14607, United States
Sanofi-Aventis Investigational Site Number 840284
The Bronx, New York, United States
Sanofi-Aventis Investigational Site Number 840056
Westfield, New York, 14787, United States
Sanofi-Aventis Investigational Site Number 840277
Greensboro, North Carolina, 27401, United States
Sanofi-Aventis Investigational Site Number 840196
Greensboro, North Carolina, 27408, United States
Sanofi-Aventis Investigational Site Number 840127
Hickory, North Carolina, 28602, United States
Sanofi-Aventis Investigational Site Number 840150
Raleigh, North Carolina, 27615, United States
Sanofi-Aventis Investigational Site Number 840185
Rocky Mount, North Carolina, 27804, United States
Sanofi-Aventis Investigational Site Number 840020
Fargo, North Dakota, 58103, United States
Sanofi-Aventis Investigational Site Number 840197
Centerville, Ohio, 45459, United States
Sanofi-Aventis Investigational Site Number 840074
Cincinnati, Ohio, 45267-0525, United States
Sanofi-Aventis Investigational Site Number 840146
Cleveland, Ohio, 44109, United States
Sanofi-Aventis Investigational Site Number 840292
Gallipolis, Ohio, 45631, United States
Sanofi-Aventis Investigational Site Number 840026
Mason, Ohio, 45040, United States
Sanofi-Aventis Investigational Site Number 840233
Toledo, Ohio, 43608, United States
Sanofi-Aventis Investigational Site Number 840064
Wadsworth, Ohio, 44281, United States
Sanofi-Aventis Investigational Site Number 840045
Oklahoma City, Oklahoma, 73104, United States
Sanofi-Aventis Investigational Site Number 840133
Tulsa, Oklahoma, 74104, United States
Sanofi-Aventis Investigational Site Number 840113
Bend, Oregon, 97701, United States
Sanofi-Aventis Investigational Site Number 840257
Portland, Oregon, 97220, United States
Sanofi-Aventis Investigational Site Number 840304
Indiana, Pennsylvania, 15701, United States
Sanofi-Aventis Investigational Site Number 840128
Philadelphia, Pennsylvania, 19102, United States
Sanofi-Aventis Investigational Site Number 840160
Philadelphia, Pennsylvania, 19143, United States
Sanofi-Aventis Investigational Site Number 840339
Philadelphia, Pennsylvania, 19149, United States
Sanofi-Aventis Investigational Site Number 840181
Pittsburgh, Pennsylvania, 15240, United States
Sanofi-Aventis Investigational Site Number 840229
Scotland, Pennsylvania, 17254, United States
Sanofi-Aventis Investigational Site Number 840072
Stoneboro, Pennsylvania, 16153, United States
Sanofi-Aventis Investigational Site Number 840248
Cranston, Rhode Island, 02920, United States
Sanofi-Aventis Investigational Site Number 840261
Anderson, South Carolina, 29621, United States
Sanofi-Aventis Investigational Site Number 840297
Anderson, South Carolina, 29621, United States
Sanofi-Aventis Investigational Site Number 840172
Camden, South Carolina, 29020, United States
Sanofi-Aventis Investigational Site Number 840168
Columbia, South Carolina, 29201, United States
Sanofi-Aventis Investigational Site Number 840122
Manning, South Carolina, 29102, United States
Sanofi-Aventis Investigational Site Number 840085
Newberry, South Carolina, 29108, United States
Sanofi-Aventis Investigational Site Number 840189
Pelzer, South Carolina, 29669, United States
Sanofi-Aventis Investigational Site Number 840032
Fort Meade, South Dakota, 57741, United States
Sanofi-Aventis Investigational Site Number 840062
Athens, Tennessee, 37303, United States
Sanofi-Aventis Investigational Site Number 840048
Bristol, Tennessee, 37620, United States
Sanofi-Aventis Investigational Site Number 840052
Bristol, Tennessee, 37620, United States
Sanofi-Aventis Investigational Site Number 840104
Cleveland, Tennessee, 37312, United States
Sanofi-Aventis Investigational Site Number 840129
Johnson City, Tennessee, 37614, United States
Sanofi-Aventis Investigational Site Number 840269
Nashville, Tennessee, 37203, United States
Sanofi-Aventis Investigational Site Number 840076
Amarillo, Texas, 79106, United States
Sanofi-Aventis Investigational Site Number 840252
Corsicana, Texas, 75110, United States
Sanofi-Aventis Investigational Site Number 840286
Houston, Texas, 77070, United States
Sanofi-Aventis Investigational Site Number 840132
Irving, Texas, 75061, United States
Sanofi-Aventis Investigational Site Number 840005
Odessa, Texas, 79761, United States
Sanofi-Aventis Investigational Site Number 840289
Odessa, Texas, 79761, United States
Sanofi-Aventis Investigational Site Number 840186
San Antonio, Texas, 78234, United States
Sanofi-Aventis Investigational Site Number 840194
San Antonio, Texas, 78238, United States
Sanofi-Aventis Investigational Site Number 840236
Temple, Texas, 76508, United States
Sanofi-Aventis Investigational Site Number 840011
Victoria, Texas, 77901, United States
Sanofi-Aventis Investigational Site Number 840285
Wichita Falls, Texas, 76309, United States
Sanofi-Aventis Investigational Site Number 840223
Clinton, Utah, 84015, United States
Sanofi-Aventis Investigational Site Number 840238
Salt Lake City, Utah, 84124, United States
Sanofi-Aventis Investigational Site Number 840308
Salt Lake City, Utah, 84124, United States
Sanofi-Aventis Investigational Site Number 840068
Salem, Virginia, 24153, United States
Sanofi-Aventis Investigational Site Number 840219
Springfield, Virginia, 22151, United States
Sanofi-Aventis Investigational Site Number 840058
Everett, Washington, 98201, United States
Sanofi-Aventis Investigational Site Number 840123
Seattle, Washington, 98111, United States
Sanofi-Aventis Investigational Site Number 840019
Tacoma, Washington, 98405, United States
Sanofi-Aventis Investigational Site Number 840256
Beloit, Wisconsin, 53511, United States
Sanofi-Aventis Investigational Site Number 840293
Madison, Wisconsin, 53713, United States
Sanofi-Aventis Investigational Site Number 840282
Wauwatosa, Wisconsin, 53226, United States
Sanofi-Aventis Investigational Site Number 032007
Buenos Aires, 1221, Argentina
Sanofi-Aventis Investigational Site Number 032011
Buenos Aires, 1416, Argentina
Sanofi-Aventis Investigational Site Number 032001
Buenos Aires, C1428AQK, Argentina
Sanofi-Aventis Investigational Site Number 032005
Buenos Aires, C1437JCP, Argentina
Sanofi-Aventis Investigational Site Number 032009
Capital Federal, C1094AAD, Argentina
Sanofi-Aventis Investigational Site Number 032012
Corrientes, 3400, Argentina
Sanofi-Aventis Investigational Site Number 032006
Mar del Plata, 7600, Argentina
Sanofi-Aventis Investigational Site Number 032014
Morón, Argentina
Sanofi-Aventis Investigational Site Number 032016
Salta, 4400, Argentina
Sanofi-Aventis Investigational Site Number 032010
Zárate, 2800, Argentina
Sanofi-Aventis Investigational Site Number 036006
Adelaide, 5035, Australia
Sanofi-Aventis Investigational Site Number 036003
Auchenflower, 4066, Australia
Sanofi-Aventis Investigational Site Number 036008
Box Hill, 3128, Australia
Sanofi-Aventis Investigational Site Number 036005
Coffs Harbour, 2450, Australia
Sanofi-Aventis Investigational Site Number 036001
Kippa-Ring, 4021, Australia
Sanofi-Aventis Investigational Site Number 036002
Kippa-Ring, 4021, Australia
Sanofi-Aventis Investigational Site Number 036009
Launceston, 7250, Australia
Sanofi-Aventis Investigational Site Number 036010
Woden, 2606, Australia
Sanofi-Aventis Investigational Site Number 040001
Graz, 8036, Austria
Sanofi-Aventis Investigational Site Number 040004
Linz, 4021, Austria
Sanofi-Aventis Investigational Site Number 112001
Minsk, 220013, Belarus
Sanofi-Aventis Investigational Site Number 112002
Minsk, 220116, Belarus
Sanofi-Aventis Investigational Site Number 112003
Minsk, 220116, Belarus
Sanofi-Aventis Investigational Site Number 112005
Minsk, 220600, Belarus
Sanofi-Aventis Investigational Site Number 076019
Belo Horizonte, 30150-221, Brazil
Sanofi-Aventis Investigational Site Number 076011
Campina Grande do Sul, 83430-000, Brazil
Sanofi-Aventis Investigational Site Number 076007
Campinas, 13059-740, Brazil
Sanofi-Aventis Investigational Site Number 076013
Campinas, 13083-190, Brazil
Sanofi-Aventis Investigational Site Number 076001
Curitiba, 80730-150, Brazil
Sanofi-Aventis Investigational Site Number 076017
Goiânia, 74223-130, Brazil
Sanofi-Aventis Investigational Site Number 076016
Goiânia, 74605-020, Brazil
Sanofi-Aventis Investigational Site Number 076018
Maceió, 57021-500, Brazil
Sanofi-Aventis Investigational Site Number 076012
Porto Alegre, 90610-000, Brazil
Sanofi-Aventis Investigational Site Number 076008
Porto Alegre, 90810-120, Brazil
Sanofi-Aventis Investigational Site Number 076014
Porto Alegre, 91350 200, Brazil
Sanofi-Aventis Investigational Site Number 076009
Recife, 52051-380, Brazil
Sanofi-Aventis Investigational Site Number 076005
São José do Rio Preto, 15015-210, Brazil
Sanofi-Aventis Investigational Site Number 076010
São Paulo, 04024-002, Brazil
Sanofi-Aventis Investigational Site Number 076015
Uberlândia, 38400 299, Brazil
Sanofi-Aventis Investigational Site Number 100004
Pleven, 5800, Bulgaria
Sanofi-Aventis Investigational Site Number 100005
Plovdiv, 4003, Bulgaria
Sanofi-Aventis Investigational Site Number 100001
Sofia, 1309, Bulgaria
Sanofi-Aventis Investigational Site Number 100002
Sofia, 1606, Bulgaria
Sanofi-Aventis Investigational Site Number 100003
Sofia, 1618, Bulgaria
Sanofi-Aventis Investigational Site Number 124014
London, N6A 5A5, Canada
Sanofi-Aventis Investigational Site Number 124006
Newmarket, L3Y 8C3, Canada
Sanofi-Aventis Investigational Site Number 124012
Québec, G1V 4G5, Canada
Sanofi-Aventis Investigational Site Number 124011
Toronto, M5G 2C4, Canada
Sanofi-Aventis Investigational Site Number 152007
Santiago, 750-0691, Chile
Sanofi-Aventis Investigational Site Number 152001
Santiago, 8053095, Chile
Sanofi-Aventis Investigational Site Number 152003
Santiago, Chile
Sanofi-Aventis Investigational Site Number 152004
Santiago, Chile
Sanofi-Aventis Investigational Site Number 152005
Santiago, Chile
Sanofi-Aventis Investigational Site Number 152008
Santiago, Chile
Sanofi-Aventis Investigational Site Number 152009
Viña del Mar, 257-0017, Chile
Sanofi-Aventis Investigational Site Number 152006
Viña del Mar, Chile
Sanofi-Aventis Investigational Site Number 170003
Bogotá, Colombia
Sanofi-Aventis Investigational Site Number 170006
Bogotá, Colombia
Sanofi-Aventis Investigational Site Number 170001
Bucaramanga, Colombia
Sanofi-Aventis Investigational Site Number 170005
Envigado-Antioquia, Colombia
Sanofi-Aventis Investigational Site Number 170002
Medellín, Colombia
Sanofi-Aventis Investigational Site Number 188004
San José, Costa Rica
Sanofi-Aventis Investigational Site Number 191003
Split, 21000, Croatia
Sanofi-Aventis Investigational Site Number 191001
Zagreb, 10000, Croatia
Sanofi-Aventis Investigational Site Number 191004
Zagreb, 10000, Croatia
Sanofi-Aventis Investigational Site Number 203005
Chomutov, 43012, Czechia
Sanofi-Aventis Investigational Site Number 203003
Jihlava, 58633, Czechia
Sanofi-Aventis Investigational Site Number 203009
Ostrava Vitkovice, 70300, Czechia
Sanofi-Aventis Investigational Site Number 203001
Pardubice, 53203, Czechia
Sanofi-Aventis Investigational Site Number 203011
Plzen - Bory, 30599, Czechia
Sanofi-Aventis Investigational Site Number 203002
Prague, 12808, Czechia
Sanofi-Aventis Investigational Site Number 203004
Prague, 14059, Czechia
Sanofi-Aventis Investigational Site Number 203010
Prague, 16902, Czechia
Sanofi-Aventis Investigational Site Number 203006
Prostějov, 796 04, Czechia
Sanofi-Aventis Investigational Site Number 203008
Ústí nad Orlicí, 56218, Czechia
Sanofi-Aventis Investigational Site Number 208002
Glostrup Municipality, 2600, Denmark
Sanofi-Aventis Investigational Site Number 208001
Hellerup, 2900, Denmark
Sanofi-Aventis Investigational Site Number 208007
Hvidovre, 2650, Denmark
Sanofi-Aventis Investigational Site Number 208003
København S, 2300, Denmark
Sanofi-Aventis Investigational Site Number 208004
Odense, 5000, Denmark
Sanofi-Aventis Investigational Site Number 208006
Roskilde, 4000, Denmark
Sanofi-Aventis Investigational Site Number 208005
Svendborg, 5700, Denmark
Sanofi-Aventis Investigational Site Number 818002
Alexandria, Egypt
Sanofi-Aventis Investigational Site Number 818003
Alexandria, Egypt
Sanofi-Aventis Investigational Site Number 818004
Alexandria, Egypt
Sanofi-Aventis Investigational Site Number 818001
Cairo, Egypt
Sanofi-Aventis Investigational Site Number 233003
Tallinn, 10138, Estonia
Sanofi-Aventis Investigational Site Number 233004
Tallinn, 13415, Estonia
Sanofi-Aventis Investigational Site Number 233001
Tallinn, 13419, Estonia
Sanofi-Aventis Investigational Site Number 233002
Tartu, 50410, Estonia
Sanofi-Aventis Investigational Site Number 246001
Helsinki, 00290, Finland
Sanofi-Aventis Investigational Site Number 250028
Abbeville, 80142, France
Sanofi-Aventis Investigational Site Number 250012
Albi, 81013, France
Sanofi-Aventis Investigational Site Number 250034
Allauch, 13190, France
Sanofi-Aventis Investigational Site Number 250031
Belfort, 90016, France
Sanofi-Aventis Investigational Site Number 250011
Bordeaux, 33076, France
Sanofi-Aventis Investigational Site Number 250010
Brest, 29609, France
Sanofi-Aventis Investigational Site Number 250021
Brest, 29609, France
Sanofi-Aventis Investigational Site Number 250035
Bron, 69677, France
Sanofi-Aventis Investigational Site Number 250022
Cholet, 49300, France
Sanofi-Aventis Investigational Site Number 250006
Dijon, 21033, France
Sanofi-Aventis Investigational Site Number 250018
Dijon, 21034, France
Sanofi-Aventis Investigational Site Number 250004
La Rochelle, 17019, France
Sanofi-Aventis Investigational Site Number 250029
Le Chesnay, 78187, France
Sanofi-Aventis Investigational Site Number 250019
Lille, 59020, France
Sanofi-Aventis Investigational Site Number 250015
Lille, 59037, France
Sanofi-Aventis Investigational Site Number 250030
Metz-Tessy, 74370, France
Sanofi-Aventis Investigational Site Number 250003
Montpellier, 34295, France
Sanofi-Aventis Investigational Site Number 250032
Montpellier, 59523, France
Sanofi-Aventis Investigational Site Number 250016
Nice, 06006, France
Sanofi-Aventis Investigational Site Number 250001
Paris, 75018, France
Sanofi-Aventis Investigational Site Number 250014
Paris, 75651, France
Sanofi-Aventis Investigational Site Number 250008
Paris, 75674, France
Sanofi-Aventis Investigational Site Number 250005
Saint-Etienne, 42055, France
Sanofi-Aventis Investigational Site Number 250026
Toulouse, 31059, France
Sanofi-Aventis Investigational Site Number 250027
Tours, 37044, France
Sanofi-Aventis Investigational Site Number 250002
Vandœuvre-lès-Nancy, 54511, France
Sanofi-Aventis Investigational Site Number 300009
Athens, 11521, Greece
Sanofi-Aventis Investigational Site Number 300007
Athens, 11527, Greece
Sanofi-Aventis Investigational Site Number 300002
Athens, 11538, Greece
Sanofi-Aventis Investigational Site Number 300005
Athens, Greece
Sanofi-Aventis Investigational Site Number 300006
Chalcis, 34 100, Greece
Sanofi-Aventis Investigational Site Number 300004
Chios, Greece
Sanofi-Aventis Investigational Site Number 300008
Elefsina, 19600, Greece
Sanofi-Aventis Investigational Site Number 320002
Guatemala City, 01010, Guatemala
Sanofi-Aventis Investigational Site Number 320001
Guatemala City, 01014, Guatemala
Sanofi-Aventis Investigational Site Number 320003
Guatemala City, 01014, Guatemala
Sanofi-Aventis Investigational Site Number 320004
Guatemala City, Guatemala
Sanofi-Aventis Investigational Site Number 356001
Ahmedabad, 380 015, India
Sanofi-Aventis Investigational Site Number 356010
Ahmedabad, 380054, India
Sanofi-Aventis Investigational Site Number 356015
Bangalore, 560034, India
Sanofi-Aventis Investigational Site Number 356009
Bangalore, 562 150, India
Sanofi-Aventis Investigational Site Number 356005
Chennai, 600 037, India
Sanofi-Aventis Investigational Site Number 356002
Coimbatore, 641004, India
Sanofi-Aventis Investigational Site Number 356007
Coimbatore, 641014, India
Sanofi-Aventis Investigational Site Number 356013
Lucknow, 226003, India
Sanofi-Aventis Investigational Site Number 356006
Lucknow, 226014, India
Sanofi-Aventis Investigational Site Number 356017
Mumbai, 54, India
Sanofi-Aventis Investigational Site Number 356014
Mysore, 570020, India
Sanofi-Aventis Investigational Site Number 356020
Nashik, 42003, India
Sanofi-Aventis Investigational Site Number 356004
New Delhi, 110060, India
Sanofi-Aventis Investigational Site Number 356012
New Delhi, India
Sanofi-Aventis Investigational Site Number 356018
Pune, 400011, India
Sanofi-Aventis Investigational Site Number 356011
Pune, 411004, India
Sanofi-Aventis Investigational Site Number 356003
Secunderabad, 500 003, India
Sanofi-Aventis Investigational Site Number 360002
Jakarta, 10430, Indonesia
Sanofi-Aventis Investigational Site Number 360001
Jakarta, Indonesia
Sanofi-Aventis Investigational Site Number 376003
Afula, 18101, Israel
Sanofi-Aventis Investigational Site Number 376015
Ashkelon, 78278, Israel
Sanofi-Aventis Investigational Site Number 376001
Giv‘atayim, 53583, Israel
Sanofi-Aventis Investigational Site Number 376007
Haifa, 31048, Israel
Sanofi-Aventis Investigational Site Number 376014
Haifa, 31096, Israel
Sanofi-Aventis Investigational Site Number 376004
Holon, 58100, Israel
Sanofi-Aventis Investigational Site Number 376012
Nahariya, 22100, Israel
Sanofi-Aventis Investigational Site Number 376009
Nazareth, 16100, Israel
Sanofi-Aventis Investigational Site Number 376011
Rehovot, 76100, Israel
Sanofi-Aventis Investigational Site Number 376002
Tel Aviv, 64239, Israel
Sanofi-Aventis Investigational Site Number 380015
Ascoli Piceno, 63100, Italy
Sanofi-Aventis Investigational Site Number 380018
Borgo San Lorenzo, 50032, Italy
Sanofi-Aventis Investigational Site Number 380016
Chieti, 66013, Italy
Sanofi-Aventis Investigational Site Number 380005
Fidenza, 43036, Italy
Sanofi-Aventis Investigational Site Number 380010
Merate, 23807, Italy
Sanofi-Aventis Investigational Site Number 380014
Milan, 20132, Italy
Sanofi-Aventis Investigational Site Number 380020
Novara, 28100, Italy
Sanofi-Aventis Investigational Site Number 380001
Padua, 35128, Italy
Sanofi-Aventis Investigational Site Number 380007
Padua, 35128, Italy
Sanofi-Aventis Investigational Site Number 380004
Palermo, 90127, Italy
Sanofi-Aventis Investigational Site Number 380008
Pavia, 27100, Italy
Sanofi-Aventis Investigational Site Number 380021
Perugia, 06132, Italy
Sanofi-Aventis Investigational Site Number 380013
San Daniele del Friuli, 33038, Italy
Sanofi-Aventis Investigational Site Number 380003
Sassari, 07100, Italy
Sanofi-Aventis Investigational Site Number 380011
Torino, 10144, Italy
Sanofi-Aventis Investigational Site Number 380009
Treviso, 31100, Italy
Sanofi-Aventis Investigational Site Number 440004
Kaunas, 3007, Lithuania
Sanofi-Aventis Investigational Site Number 440002
Kaunas, LT-49456, Lithuania
Sanofi-Aventis Investigational Site Number 440003
Vilnius, LT-07156, Lithuania
Sanofi-Aventis Investigational Site Number 440001
Vilnius, LT-08661, Lithuania
Sanofi-Aventis Investigational Site Number 458002
George Town, 10450, Malaysia
Sanofi-Aventis Investigational Site Number 458001
Kuching, 93586, Malaysia
Sanofi-Aventis Investigational Site Number 458005
Taiping, 34000, Malaysia
Sanofi-Aventis Investigational Site Number 484008
Acapulco, 39670, Mexico
Sanofi-Aventis Investigational Site Number 484013
Aguascalientes, 20230, Mexico
Sanofi-Aventis Investigational Site Number 484016
Aguascalientes, 20230, Mexico
Sanofi-Aventis Investigational Site Number 484004
Guadalajara, 4428, Mexico
Sanofi-Aventis Investigational Site Number 484007
Guadalajara, 44340, Mexico
Sanofi-Aventis Investigational Site Number 484012
Mexico City, 07300, Mexico
Sanofi-Aventis Investigational Site Number 484010
Monterrey, 64060, Mexico
Sanofi-Aventis Investigational Site Number 484011
San Luis Potosí City, 72244, Mexico
Sanofi-Aventis Investigational Site Number 484005
San Luis Potosí City, 78200, Mexico
Sanofi-Aventis Investigational Site Number 484003
Veracruz, 91700, Mexico
Sanofi-Aventis Investigational Site Number 504001
Marrakesh, 40000, Morocco
Sanofi-Aventis Investigational Site Number 504002
Meknes, 50000, Morocco
Sanofi-Aventis Investigational Site Number 528012
Almelo, 7609 PP, Netherlands
Sanofi-Aventis Investigational Site Number 528030
Amsterdam, 1066 EC, Netherlands
Sanofi-Aventis Investigational Site Number 528026
Breda, 4818 CK, Netherlands
Sanofi-Aventis Investigational Site Number 528009
Delft, 2526 AD, Netherlands
Sanofi-Aventis Investigational Site Number 528027
Ede, 6716 RP, Netherlands
Sanofi-Aventis Investigational Site Number 528006
Eindhoven, 5623 EJ, Netherlands
Sanofi-Aventis Investigational Site Number 528017
Eindhoven, 5623 EJ, Netherlands
Sanofi-Aventis Investigational Site Number 528016
Gouda, 2803 HH, Netherlands
Sanofi-Aventis Investigational Site Number 528007
Harderwijk, 3844 DG, Netherlands
Sanofi-Aventis Investigational Site Number 528001
Heerlen, 6419 PC, Netherlands
Sanofi-Aventis Investigational Site Number 528024
Heerlen, 6419 PC, Netherlands
Sanofi-Aventis Investigational Site Number 528003
Hengelo, 7555 DL, Netherlands
Sanofi-Aventis Investigational Site Number 528010
Hengelo, 7555 DL, Netherlands
Sanofi-Aventis Investigational Site Number 528031
Hoogeveen, 7909 AA, Netherlands
Sanofi-Aventis Investigational Site Number 528019
Hoorn, 1625 HV, Netherlands
Sanofi-Aventis Investigational Site Number 528020
Leeuwarden, 8934 AD, Netherlands
Sanofi-Aventis Investigational Site Number 528004
Nijmegen, 6532 SZ, Netherlands
Sanofi-Aventis Investigational Site Number 528013
Rotterdam, 3083 AN, Netherlands
Sanofi-Aventis Investigational Site Number 528022
Sittard-Geleen, 6162 BG, Netherlands
Sanofi-Aventis Investigational Site Number 528002
Sneek, 8601 ZK, Netherlands
Sanofi-Aventis Investigational Site Number 528035
The Hague, 2545 CH, Netherlands
Sanofi-Aventis Investigational Site Number 528033
Tilburg, 5022 GC, Netherlands
Sanofi-Aventis Investigational Site Number 528021
Venlo, 5912 BL, Netherlands
Sanofi-Aventis Investigational Site Number 528005
Zoetermeer, 2725 NA, Netherlands
Sanofi-Aventis Investigational Site Number 528025
Zwolle, 8011 JW, Netherlands
Sanofi-Aventis Investigational Site Number 554003
Christchurch, New Zealand
Sanofi-Aventis Investigational Site Number 554002
Dunedin, New Zealand
Sanofi-Aventis Investigational Site Number 554001
Nelson, New Zealand
Sanofi-Aventis Investigational Site Number 578001
Bergen, 5021, Norway
Sanofi-Aventis Investigational Site Number 578006
Flekkefjord, 4400, Norway
Sanofi-Aventis Investigational Site Number 578005
Lørenskog, 1478, Norway
Sanofi-Aventis Investigational Site Number 578004
Oslo, 0027, Norway
Sanofi-Aventis Investigational Site Number 591001
Panama City, Panama
Sanofi-Aventis Investigational Site Number 591002
Panama City, Panama
Sanofi-Aventis Investigational Site Number 591003
Panama City, Panama
Sanofi-Aventis Investigational Site Number 604004
Lima, CALLAO 2, Peru
Sanofi-Aventis Investigational Site Number 604002
Lima, Lima 11, Peru
Sanofi-Aventis Investigational Site Number 604001
Lima, LIMA 13, Peru
Sanofi-Aventis Investigational Site Number 604005
Lima, LIMA 31, Peru
Sanofi-Aventis Investigational Site Number 604003
Lima, LIMA 41, Peru
Sanofi-Aventis Investigational Site Number 608001
Quezon City, 1102, Philippines
Sanofi-Aventis Investigational Site Number 616013
Chojnice, 89-600, Poland
Sanofi-Aventis Investigational Site Number 616011
Gdansk, 81-756, Poland
Sanofi-Aventis Investigational Site Number 616014
Gdynia-Redlowo, 81-402, Poland
Sanofi-Aventis Investigational Site Number 616009
Katowice, 40-635, Poland
Sanofi-Aventis Investigational Site Number 616017
Lodz, 91-425, Poland
Sanofi-Aventis Investigational Site Number 616002
Lublin, 20-954, Poland
Sanofi-Aventis Investigational Site Number 616012
Ostrowiec Świętokrzyski, 27-400, Poland
Sanofi-Aventis Investigational Site Number 616015
Puławy, 24-100, Poland
Sanofi-Aventis Investigational Site Number 616007
Torun, 87-100, Poland
Sanofi-Aventis Investigational Site Number 616006
Tychy, 43-100, Poland
Sanofi-Aventis Investigational Site Number 616001
Warsaw, 02-005, Poland
Sanofi-Aventis Investigational Site Number 616010
Warsaw, 02-097, Poland
Sanofi-Aventis Investigational Site Number 616008
Wroclaw, 50-349, Poland
Sanofi-Aventis Investigational Site Number 620002
Amadora, 2720-276, Portugal
Sanofi-Aventis Investigational Site Number 620007
Braga, 4701-968, Portugal
Sanofi-Aventis Investigational Site Number 620006
Coimbra, 3000-075, Portugal
Sanofi-Aventis Investigational Site Number 620008
Setúbal, 2910-446, Portugal
Sanofi-Aventis Investigational Site Number 630001
San Juan, 00921-3201, Puerto Rico
Sanofi-Aventis Investigational Site Number 643033
Barnaul, 656055, Russia
Sanofi-Aventis Investigational Site Number 643040
Chelyabinsk, 454048, Russia
Sanofi-Aventis Investigational Site Number 643050
Chelyabinsk, 454092, Russia
Sanofi-Aventis Investigational Site Number 643036
Chelyabinsk, 454136, Russia
Sanofi-Aventis Investigational Site Number 643009
Kemerovo, 650002, Russia
Sanofi-Aventis Investigational Site Number 643042
Kemerovo, 650002, Russia
Sanofi-Aventis Investigational Site Number 643015
Moscow, 105066, Russia
Sanofi-Aventis Investigational Site Number 643032
Moscow, 109263, Russia
Sanofi-Aventis Investigational Site Number 643007
Moscow, 111539, Russia
Sanofi-Aventis Investigational Site Number 643020
Moscow, 117292, Russia
Sanofi-Aventis Investigational Site Number 643054
Moscow, 117342, Russia
Sanofi-Aventis Investigational Site Number 643052
Moscow, 117556, Russia
Sanofi-Aventis Investigational Site Number 643056
Moscow, 119415, Russia
Sanofi-Aventis Investigational Site Number 643025
Moscow, 119435, Russia
Sanofi-Aventis Investigational Site Number 643053
Moscow, 119435, Russia
Sanofi-Aventis Investigational Site Number 643028
Moscow, 121359, Russia
Sanofi-Aventis Investigational Site Number 643037
Moscow, 121359, Russia
Sanofi-Aventis Investigational Site Number 643001
Moscow, 121552, Russia
Sanofi-Aventis Investigational Site Number 643026
Moscow, 121552, Russia
Sanofi-Aventis Investigational Site Number 643039
Moscow, 121552, Russia
Sanofi-Aventis Investigational Site Number 643011
Moscow, 127473, Russia
Sanofi-Aventis Investigational Site Number 643034
Moscow, 127473, Russia
Sanofi-Aventis Investigational Site Number 643049
Moscow, 129090, Russia
Sanofi-Aventis Investigational Site Number 643030
Moscow, 129336, Russia
Sanofi-Aventis Investigational Site Number 643013
Nizhny Novgorod, 603003, Russia
Sanofi-Aventis Investigational Site Number 643041
Nizniy Novgorod, 603005, Russia
Sanofi-Aventis Investigational Site Number 643051
Novosibirsk, 630008, Russia
Sanofi-Aventis Investigational Site Number 643044
Novosibirsk, 630091, Russia
Sanofi-Aventis Investigational Site Number 643048
Novosibirsk-117, 630117, Russia
Sanofi-Aventis Investigational Site Number 643045
Penza, Russia
Sanofi-Aventis Investigational Site Number 643023
Perm, 614097, Russia
Sanofi-Aventis Investigational Site Number 643006
Perm, 614107, Russia
Sanofi-Aventis Investigational Site Number 643046
Petrozavodsk, 185019, Russia
Sanofi-Aventis Investigational Site Number 643012
Rostov-on-Don, 344068, Russia
Sanofi-Aventis Investigational Site Number 643008
Ryazan, 390026, Russia
Sanofi-Aventis Investigational Site Number 643022
Saint Petersburg, 192242, Russia
Sanofi-Aventis Investigational Site Number 643038
Saint Petersburg, 194354, Russia
Sanofi-Aventis Investigational Site Number 643016
Saint Petersburg, 196247, Russia
Sanofi-Aventis Investigational Site Number 643017
Saint Petersburg, 197022, Russia
Sanofi-Aventis Investigational Site Number 643047
Saint Petersburg, 197022, Russia
Sanofi-Aventis Investigational Site Number 643018
Saint Petersburg, 197110, Russia
Sanofi-Aventis Investigational Site Number 643010
Saint Petersburg, 198013, Russia
Sanofi-Aventis Investigational Site Number 643027
Saint Petersburg, 198013, Russia
Sanofi-Aventis Investigational Site Number 643002
Saint Petersburg, 199106, Russia
Sanofi-Aventis Investigational Site Number 643029
Samara, 443070, Russia
Sanofi-Aventis Investigational Site Number 643004
Saratov, 410028, Russia
Sanofi-Aventis Investigational Site Number 643005
Saratov, 410028, Russia
Sanofi-Aventis Investigational Site Number 643003
Saratov, 410054, Russia
Sanofi-Aventis Investigational Site Number 643024
Tomsk, 634012, Russia
Sanofi-Aventis Investigational Site Number 643035
Tomsk, 634012, Russia
Sanofi-Aventis Investigational Site Number 643021
Tyumen, 625023, Russia
Sanofi-Aventis Investigational Site Number 643043
Voronezh, 394006, Russia
Sanofi-Aventis Investigational Site Number 643019
Yaroslavl, 150062, Russia
Sanofi-Aventis Investigational Site Number 643031
Yekaterinburg, 620109, Russia
Sanofi-Aventis Investigational Site Number 703003
Košice, 04015, Slovakia
Sanofi-Aventis Investigational Site Number 703005
Levice, Slovakia
Sanofi-Aventis Investigational Site Number 703004
Nitra, 950 01, Slovakia
Sanofi-Aventis Investigational Site Number 703006
Poprad, 05845, Slovakia
Sanofi-Aventis Investigational Site Number 703002
Trnava, 91775, Slovakia
Sanofi-Aventis Investigational Site Number 710011
Bloemfontein, South Africa
Sanofi-Aventis Investigational Site Number 710007
Cape Town, 7129, South Africa
Sanofi-Aventis Investigational Site Number 710017
Cape Town, 7764, South Africa
Sanofi-Aventis Investigational Site Number 710001
Durban, 4092, South Africa
Sanofi-Aventis Investigational Site Number 710012
Durban, South Africa
Sanofi-Aventis Investigational Site Number 710013
eManzimtoti, South Africa
Sanofi-Aventis Investigational Site Number 710009
Johannesburg, 1449, South Africa
Sanofi-Aventis Investigational Site Number 710016
Port Elizabeth, South Africa
Sanofi-Aventis Investigational Site Number 710020
Pretoria, 0050, South Africa
Sanofi-Aventis Investigational Site Number 710003
Pretoria, 0084, South Africa
Sanofi-Aventis Investigational Site Number 710002
Pretoria, 0204, South Africa
Sanofi-Aventis Investigational Site Number 710015
Randburg, 2194, South Africa
Sanofi-Aventis Investigational Site Number 710014
Scottburgh, South Africa
Sanofi-Aventis Investigational Site Number 710018
Umhlanga, 4400, South Africa
Sanofi-Aventis Investigational Site Number 410008
Anyang, 431-070, South Korea
Sanofi-Aventis Investigational Site Number 410002
Daegu, 700-712, South Korea
Sanofi-Aventis Investigational Site Number 410006
Goyang, 411-706, South Korea
Sanofi-Aventis Investigational Site Number 410012
Goyang, 411-773, South Korea
Sanofi-Aventis Investigational Site Number 410007
Gwangju, 501-757, South Korea
Sanofi-Aventis Investigational Site Number 410003
Seongnam, 463-802, South Korea
Sanofi-Aventis Investigational Site Number 410001
Seoul, 134-701, South Korea
Sanofi-Aventis Investigational Site Number 410004
Seoul, 135-710, South Korea
Sanofi-Aventis Investigational Site Number 410005
Seoul, 138-736, South Korea
Sanofi-Aventis Investigational Site Number 410011
Seoul, 140-210, South Korea
Sanofi-Aventis Investigational Site Number 724003
Barcelona, 08003, Spain
Sanofi-Aventis Investigational Site Number 724002
Barcelona, 08036, Spain
Sanofi-Aventis Investigational Site Number 724001
Madrid, 28046, Spain
Sanofi-Aventis Investigational Site Number 724005
Santiago de Compostela, 15706, Spain
Sanofi-Aventis Investigational Site Number 724007
Seville, 41006, Spain
Sanofi-Aventis Investigational Site Number 752003
Gothenburg, 413 45, Sweden
Sanofi-Aventis Investigational Site Number 752006
Gothenburg, 413 45, Sweden
Sanofi-Aventis Investigational Site Number 752002
Malmo, 20502, Sweden
Sanofi-Aventis Investigational Site Number 752007
Malmo, 211 52, Sweden
Sanofi-Aventis Investigational Site Number 752004
Östersund, 831 83, Sweden
Sanofi-Aventis Investigational Site Number 752001
Stockholm, SE-171 76, Sweden
Sanofi-Aventis Investigational Site Number 158003
Kaohsiung City, 833, Taiwan
Sanofi-Aventis Investigational Site Number 158002
Taichung, Taiwan
Sanofi-Aventis Investigational Site Number 158004
Tainan Hsien, 710, Taiwan
Sanofi-Aventis Investigational Site Number 158001
Taipei, Taiwan
Sanofi-Aventis Investigational Site Number 158005
Taipei, Taiwan
Sanofi-Aventis Investigational Site Number 764001
Bangkok, 10330, Thailand
Sanofi-Aventis Investigational Site Number 764002
Bangkok Noi, 10700, Thailand
Sanofi-Aventis Investigational Site Number 764003
Muang, 50200, Thailand
Sanofi-Aventis Investigational Site Number 792004
Edirne, Turkey (Türkiye)
Sanofi-Aventis Investigational Site Number 792005
Edirne, Turkey (Türkiye)
Sanofi-Aventis Investigational Site Number 792002
Istanbul, 34034, Turkey (Türkiye)
Sanofi-Aventis Investigational Site Number 792001
Istanbul, Turkey (Türkiye)
Sanofi-Aventis Investigational Site Number 792003
Istanbul, Turkey (Türkiye)
Sanofi-Aventis Investigational Site Number 792006
Kocaeli, 41300, Turkey (Türkiye)
Sanofi-Aventis Investigational Site Number 792007
Kocaeli, 41380, Turkey (Türkiye)
Sanofi-Aventis Investigational Site Number 804013
Dnipro, Ukraine
Sanofi-Aventis Investigational Site Number 804015
Dnipro, Ukraine
Sanofi-Aventis Investigational Site Number 804005
Dnipropetrovsk, Ukraine
Sanofi-Aventis Investigational Site Number 804008
Ivano-Frankivsk, Ukraine
Sanofi-Aventis Investigational Site Number 804002
Kharkiv, Ukraine
Sanofi-Aventis Investigational Site Number 804004
Kharkiv, Ukraine
Sanofi-Aventis Investigational Site Number 804012
Kharkiv, Ukraine
Sanofi-Aventis Investigational Site Number 804003
Kiev, Ukraine
Sanofi-Aventis Investigational Site Number 804007
Lutsk, Ukraine
Sanofi-Aventis Investigational Site Number 804009
Lutsk, Ukraine
Sanofi-Aventis Investigational Site Number 804011
Odesa, Ukraine
Sanofi-Aventis Investigational Site Number 804010
Ternopil, Ukraine
Sanofi-Aventis Investigational Site Number 804006
Uzhhorod, Ukraine
Sanofi-Aventis Investigational Site Number 804014
Zaporizhzhia, Ukraine
Sanofi-Aventis Investigational Site Number 862001
Caracas, Venezuela
Sanofi-Aventis Investigational Site Number 862002
Maracay, 2103, Venezuela
Related Publications (1)
Buller HR, Halperin J, Hankey GJ, Pillion G, Prins MH, Raskob GE. Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study. J Thromb Haemost. 2014 Jun;12(6):824-30. doi: 10.1111/jth.12546.
PMID: 24597472RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Clinical Sciences & Operations
Sanofi
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 21, 2007
First Posted
December 24, 2007
Study Start
December 1, 2007
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
March 21, 2016
Record last verified: 2016-02